Challenges and Driving Forces for Business Plans in Biobanking
Macheiner, T. et al. Biopreservation and Biobanking 2017 Apr 13; 15(2): 121-125.
The Need for Research Infrastructures: A Narrative Review of Large-Scale Research Infrastructures in Biobanking
Larsson, A. Biopreservation and Biobanking 2017 Feb 21; Epub.
Quality Management of Biorepositories
Grizzle, W.E., et al. Biopreservation and Biobanking 2015 Jun 1; 13(3): 183-194.
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC)
Patel A.A., et al. Cancer Inform. 2007 Jun 8;3:255-74.
Case studies of existing human tissue repositories: "best practices" for a biospecimen resource for the genomic and proteomic era
Eiseman E., et al. 2003. Santa Monica, CA: RAND Corporation.
Centralized biorepositories for genetic and genomic research
Ginsburg G.S., Burke T.W. and Febbo P. JAMA. 2008 Mar 19;299(11):1359-61.
Electronic medical records for genetic research: results of the eMERGE Consortium
Kho A.N., et al. Sci Transl Med. 2011 Apr 20;3(79):79re1.
Issues in collecting, processing and storing human tissues and associated information to support biomedical research
Grizzle W.E., et al. Cancer Biomark. 2010;9(1-6):531-49.
Multi-institutional tumor banking: lessons learned from a pancreatic cancer biospecimen repository
Demeure M.J., et al. Pancreas. 2010 Oct;39(7):949-54.
Review of Developing and Organizing an Institutional Biospecimen Repository, edited by Donna E. Hansel and Scott D. Jewell
Bui M. and Pham V. Biopreserv Biobank. 2015 Aug;13(4):303.
The boom and bust cycle of biobanking —thinking through the life cycle of biobanks
Tupasela A. and Stephens N. Croat Med J. 2013 Oct 28;54(5):501-3.
The Mayo Clinic Biobank: a building block for individualized medicine
Olson J.E., et al. Mayo Clin Proc. 2013 Sep;88(9):952-62.
What are the biggest challenges and opportunities for biorepositories in the next three to five years?
Betsou F., et al. Biopreserv Biobank. 2010 Jun;8(2):81-8.
Centralized biorepositories for genetic and genomic research
Ginsburg G.S., Burke T.W. and Febbo P. JAMA. 2008 Mar 19;299(11):1359-61.
Experiences with obtaining informed consent for genomic sequencing
Bernhardt B.A., et al. Am J Med Genet A. 2015 Nov;167(11):2635-46.
Public attitudes to human genetic information: People's Panel quantitative study conducted for the Human Genetics Commission
Human Genetics Commission (Great Britain). London: Human Genetics Commission, 2001 March.
Baobab Laboratory Information Management System: Development of an Open-Source Laboratory Information Management System for Biobanking
Bendou, H. et al. Biopreservation and Biobanking. 2017 Apr;15(2): 116-120.
Selecting a Laboratory Information Management System for Biorepositories in Low and Middle-Income Countries: The H3Africa Experience and Lessons Learned
Kyobe, S. et al. Biopreservation and Biobanking. 2017 Apr;15(2): 112-115.
The State of Cloud-Based Biospecimen and Biobank Data Management Tools
Paul S., Gade A., Mallipeddi S. Biopreservation and Biobanking. 2017 Mar 16;15(2).
A call to standardize preanalytic data elements for biospecimens, Part II
Robb J.A., et al. Arch Pathol Lab Med. 2015 Sep;139(9):1125-8.
A decade of experience in the development and implementation of tissue banking informatics tools for intra and inter-institutional translational research
Amin W., et al. J Pathol Inform. 2010 Aug 10;1.
An informatics model for tissue banks —Lessons learned from the Cooperative Prostate Cancer Tissue Resource
Patel A.A., et al. BMC Cancer. 2006 May 5;6:120.
Automated web-based request mechanism for workflow enhancement in an academic customer-focused biorepository
McDonald S.A., et al. Biopreserv Biobank. 2012 Feb;10(1):48-54.
BiobankConnect: software to rapidly connect data elements for pooled analysis across biobanks using ontological and lexical indexing
Pang C., et al. J Am Med Inform Assoc. 2015 Jan;22(1):65-75.
Information systems as infrastructure for university research now and in the future
Rice M.L. (Editor) 2012. University of Kansas Merrill Advanced Studies Center (1): 65–75.
Public trust in health information sharing: implications for biobanking and electronic health record systems
Platt J. and Kardia S. J Pers Med. 2015 Feb 3;5(1):3-21.
Sharing and reuse of sensitive data and samples: supporting researchers in identifying ethical and legal requirements
Sariyar M., et al. Biopreserv Biobank. 2015 Aug;13(4):263-70.
Six methodological steps to build medical data warehouses for research
Szirbika N.B., et al. Int J Med Inform. 2006 Sep;75(9):683-91.
The Enterprise Data Trust at Mayo Clinic: a semantically integrated warehouse of biomedical data
Chute C.G., et al. J Am Med Inform Assoc. 2010 Mar-Apr;17(2):131-5.
The informatics challenges facing biobanks: a perspective from a United Kingdom Biobanking Network
Quinlan P.R., et al. Biopreserv Biobank. 2015 Oct;13(5):363-70.
Biobanking with Big Data: A Need for Developing "Big Data Metrics"
Zisis, K. Biopreserv Biobank. 2016 Oct;14(5):450-1.
Standard Versus Simplified Consent Materials for Biobank Participation: Differences in Patient Knowledge and Trial Accrual
Garrett, S.B., et al. J. Empir. Res. Hum. Res. Ethics. 2017 Oct;12(4): 1-9
Ethical Legal and Social Issues of Biobanking: Past, Present, and Future
Bledsoe, M. Biopreserv Biobanking. 2017 Apr;15(2): 142-147
A systematic literature review of individuals' perspectives on broad consent and data sharing in the United States
Garrison N.A., et al. Genet Med. 2015 Nov 19.
Active choice but not too active: Public perspectives on biobank consent models
Simon C.M., et al. Genet Med. 2011 Sep;13(9):821-31.
Alternative consent approaches for biobank research
Maschke K.J. Lancet Oncol. 2006 Mar;7(3):193-4.
"Broad" consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose
Petrini C. Soc Sci Med. 2010 Jan;70(2):217-20.
Broad consent for research with biological samples: workshop conclusions
Grady C., et al. Am J Bioeth. 2015;15(9):34-42.
Developing a simplified consent form for biobanking
NIH broad sample consent form language from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS). 2014.
Dynamic consent: a patient interface for twenty-first century research networks
Kaye J., et al. Eur J Hum Genet. 2015 Feb;23(2):141-6.
EngageUC: developing an efficient and ethical approach to biobanking research at the University of California
Garrett S.B., et al. Clin Transl Sci. 2015 Aug;8(4):362-6.
Facilitating autonomy with broad consent
Spellecy R. Am J Bioeth. 2015;15(9):43-4.
Linking broad consent to biobank governance: support from a deliberative public engagement in California
Garrett S.B., et al. Am J Bioeth. 2015;15(9):56-7.
Models of consent to return of incidental findings in genomic research
Appelbaum P.S., et al. Hastings Cent Rep. 2014 Jul-Aug;44(4):22-32.
Moral concerns and the willingness to donate to a research biobank
Tomlinson T., et al. JAMA. 2015 Jan 27;313(4):417-9.
Open consent, biobanking and data protection law: can open consent be ‘informed’ under the forthcoming data protection regulation?
Hallinan D. and Friedewald M. Life Sci Soc Policy. 2015;11:1.
Research guideline recommendations for broad consent forms in biobank research and how they are currently addressed in practice
Strech D., et al. Am J Bioeth. 2015;15(9):60-3.
Researchers' views on informed consent for return of secondary results in genomic research
Appelbaum P.S., et al. Genet Med. 2015 Aug;17(8):644-50.
Should donors be allowed to give broad consent to future biobank research?
Hansson M.G., et al. Lancet Oncol. 2006 Mar;7(3):266-9.
Template for informed consent concerning the donation, storage, and utilization of biological materials as well as collecting, processing, and usage of (related) data in biobanks
Permanent Working Party of the German Medical Ethics Committees approved by the General Assembly. 2013 Sep.
Financial Sustainability of Biobanks: From Theory to Practice
Yuille M., et al. Biopreserv Biobank. 2017 Apr;15(2): 85-92.
Addressing the challenge of financial sustainability in biobanking
Campos A.H., et al. Biopreserv Biobank. 2015 Dec;13(6):387-95.
Biobank finances: a socio-economic analysis and review
Gee S., et al. Biopreserv Biobank. 2015 Dec;13(6):435-51.
Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank
Vaught J., et al. J Natl Cancer Inst Monogr. 2011;2011(42):24-31.
Finding the path to biobank sustainability through sound business planning
Henderson M., et al. Biopreserv Biobank. 2015 Dec;13(6):385-6.
Public biobanks: calculation and recovery of costs
Clément B., et al. Sci Transl Med. 2014 Nov 5;6(261):261fs45.
Sustainability in biobanking
Simeon-Dubach D. and Henderson M.K. Biopreserv Biobank. 2014 Oct;12(5):287-91.
Sustainability in the modern biorepository environment from the perspective of the Tissue Procurement Core at the University of Iowa
Galbraith J.W. Biopreserv Biobank. 2015 Dec;13(6):430-2.
How Biobanks Are Assessing and Measuring Their Financial Sustainability
Brown, T., et al. Biopreserv Biobank. 2016 Nov; 1-7 [Epub].
Methods to Improve Sustainability of a Large Academic Biorepository
Kelly, SM., et al. Biopreserv Biobank. 2016 Nov; 1-6 [Epub].
Achieving and Maintaining Sustainability in Biobanking Through Business Planning, Marketing, and Access
Henderson, MK., et al. Biopreserv Biobank. 2016 Nov; 1-2 [Epub].
ISBER Goes Global
Schacter B. Biopreserv Biobank. 2017 Apr;15(2): 173.
Banking brain tumor specimens using a university core facility
Bregy A., et al. Biopreserv Biobank. 2015 Aug;13(4):280-6.
Biobanking for research: a survey of patient population attitudes and understanding
Rahm A.K., et al. J Community Genet. 2013 Oct;4(4):445-50.
Personal medicine—the new banking crisis
Scott C.T., et al. Nat Biotechnol. 2012 Feb 8;30(2):141-7.
Providing contemporary access to historical biospecimen collections: development of the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC)
Giffen C.A., et al. Biopreserv Biobank. 2015 Aug;13(4):271-9.
Top considerations for using social media in research—it all starts with a plan
Quorum Review IRB. 2015 Sep;1-6.
Using remnant biospecimens in medical research
Medical Research Networx
The UC Davis Biorepositories Core Resource (BCR) is a shared service that develops and delivers educational, operational and research tools for researchers and biobankers who collect, store, or study biospecimens at UC Davis.
The BCR’s goal is to enhance the quality and reproducibility of biospecimen research promoting biobank education and adoption of “best practices” standards for new and existing biobanks at UC Davis.
The BCR will also serve as a cornerstone for continuous development and implementation of enterprise-wide biorepository related infrastructure. This infrastructure will facilitate the ability of UC Davis researchers to procure, process and utilize biospecimens in the most cost as well as time effective manner.
- Institutional Review Board (IRB) and Regulatory Compliance policies concerning human biospecimen procurement (integrated with established UC Davis IRB training).
- Overview: Fundamentals of creating biospecimen collection protocols and consent forms.
- Identification of established BCR infrastructure and implementation of available services.
- External web-based biobank and biorepositories specific training programs.
- Customized training to suit need of faculty, staff and/or students (upon request).
- Web Resources (e.g. Biological MTA, Handbook of Human Tissue Sources, ethical best practices).
- International Society of Biological and Environmental Repositories (ISBER) guidelines for best practices of biospecimen procurement and storage.
- National Cancer Institute–Biorepositories and Biospecimen Research Branch (BBRB) best practices.
- College of American Pathologists (CAP) Biorepository Accreditation guidelines.
- Internal: Biorepository Core Resource (BCR) services and practices to UC Davis stakeholders.
- External: Community engagement (public/private) sharing UC Davis policies of biospecimen donation and stewardship.
- Federal, state, local and University policies for human biospecimen management.
- Distribution of relevant publications, news and events in the field of biobanking to UC Davis stakeholders.
- Biorepositories Core Resource—“Learn at Lunch” noontime education series
The BCR is developing multiple enterprise-wide tools to assist researchers. Examples:
- BCR website as a centralized biospecimen and biobanking data resource for all UC Davis faculty, staff and students.
- Virtual Biospecimen Database (VBD)—organization-wide biospecimen inventory system. The BCR will develop a Virtual Biospecimen Database (VBD) among established biorepositories and/or biospecimen collections. The VBD is meant to provide a web interface for identifying stored biospecimens across existing UC Davis repositories (retrospective inventory). Investigators and their collaborators will have the ability to identify potential samples and/or create collaborations with existing biobanks or biospecimen collections for their research. The VBD is expected to become a robust conduit allowing UC Davis researchers to participate in internal and external biobanking networks in the future.
- EMR-Computerized Physician Order Entry (CPOE): Use of CPOE allows personnel (e.g. clinician, nurse, CRC) to order research-specific blood (i.e. serum, plasma, whole blood, DNA) via the EMR alone or in conjunction with clinical blood orders. This will leverage use of already established departmental and institutional resources and can reduce duplication of effort for research.
- “Broad Consent” for UC Davis Health members participating in research. Broad consent is one type of consenting approach that allows for an unspecified range of future research studies to be permitted. It is less specific than obtaining consent for each individual research study, but narrower than the open-ended permission with no limitations (i.e., “blanket consent”). The BCR will collaborate with key stakeholders within UC Davis to create a brief standard consent form approach that agrees to a general permit for future research.
Anyone (faculty, staff or students) can request a consultation to discuss their biospecimen or biorepository-related projects by calling 916-734-3475.
Once the Virtual Biospecimen Database (VBD) is developed and implemented, samples can be located from stored biospecimen inventories across UC Davis. The VBD will identify which biobanks may contain your identified samples. The requestor would contact the established biobanks to further clarify requests and ensure that investigators are in compliance with IRB regulations.
Dr. Nicholas Anderson is the BCR Director and Leslie Solis is the Biobank Operations Specialist (see “About Us” for their biographies). The BCR administrative office is located within the Clinical and Translational Science Center (CTSC, 2921 Stockton Blvd., UC Davis Medical Center).